GYRE vs PYPL · rev $53.5M vs P/E 7.9, rev $33.17B
Gyre Therapeutics Inc. (GYRE) versus PayPal Holdings Inc (PYPL) — a side-by-side from cached financials, not a winner call.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ. It is led by Alex Chriss.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
GYRE currently screens at market cap $589.9M. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Not investment advice. Open the GYRE and PYPL stock pages for the full models.
Not investment advice.